Kymera Therapeutics KYMR
NASDAQ KYMR
$134.84 -1.80 (-1.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Kymera Therapeutics (KYMR) Long-Term Investments (2020 - 2026)

Updated

Analysis

Kymera Therapeutics (KYMR) Long-Term Investments (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Kymera Therapeutics 11.66 Bn 8.50 Bn - 674.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 674.70 Mn
Jun 30, 2026 813.90 Mn
Mar 31, 2026 894.72 Mn
Dec 31, 2025 771.20 Mn
Sep 30, 2025 473.10 Mn
Jun 30, 2025 297.63 Mn
Mar 31, 2025 312.34 Mn
Dec 31, 2024 362.20 Mn
Sep 30, 2024 361.04 Mn
Jun 30, 2024 192.45 Mn
Mar 31, 2024 224.40 Mn
Dec 31, 2023 61.43 Mn
Sep 30, 2023 77.00 Mn
Jun 30, 2023 104.80 Mn
Mar 31, 2023 61.40 Mn
Dec 31, 2022 152.33 Mn
Sep 30, 2022 113.70 Mn
Jun 30, 2022 90.20 Mn
Mar 31, 2022 102.50 Mn
Dec 31, 2021 125.20 Mn
API Access

Kymera Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=KYMR&period=max&api_key=YOUR_API_KEY